CVP, CFO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Scott B. Ullem (insider trades) sold 7,500 shares of EW on 10/29/2019 at an average price of $235.3 a share. The total sale was $1.8 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $49.8 billion; its shares were traded at around $238.75 with a P/E ratio of 65.41 and P/S ratio of 12.19. Edwards Lifesciences Corp had annual average EBITDA growth of 17.70% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 4-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .
CFO Recent Trades:
- CVP, CFO Scott B. Ullem sold 7,500 shares of EW stock on 10/29/2019 at the average price of $235.3. The price of the stock has increased by 1.47% since.
Directors and Officers Recent Trades:
- CVP, Critical Care Catherine M. Szyman sold 2,500 shares of EW stock on 10/25/2019 at the average price of $227.19. The price of the stock has increased by 5.09% since.
- CVP, Japan & Intercontinental Huimin Wang sold 4,650 shares of EW stock on 10/04/2019 at the average price of $223.18. The price of the stock has increased by 6.98% since.
- CVP,Strategy/Corp Development Donald E Jr Bobo sold 5,369 shares of EW stock on 10/04/2019 at the average price of $223.18. The price of the stock has increased by 6.98% since.
- CVP, TAVR Larry L Wood sold 6,716 shares of EW stock on 10/01/2019 at the average price of $218.24. The price of the stock has increased by 9.4% since.
For the complete insider trading history of EW, click here
.
